Antibiotic self-treatment of travelers' diarrhea: It only gets worse
Even the use of loperamide has been shown to increase the risk of drug resistant gut enteric bacteria when added to antibiotic treatment of TD whereas loperamide use alone did not increase this risk [4] In fact, loperamide appears to be no less effective than an antibiotic in the management of mild...
Gespeichert in:
| Veröffentlicht in: | Travel medicine and infectious disease 2017-03, Vol.16, p.1-2 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2 |
|---|---|
| container_issue | |
| container_start_page | 1 |
| container_title | Travel medicine and infectious disease |
| container_volume | 16 |
| creator | Keystone, J.S., MD FRCPC Connor, Bradley A., MD |
| description | Even the use of loperamide has been shown to increase the risk of drug resistant gut enteric bacteria when added to antibiotic treatment of TD whereas loperamide use alone did not increase this risk [4] In fact, loperamide appears to be no less effective than an antibiotic in the management of mild to moderate travelers' diarrhea [5] Although the vast majority of those returning from international travel with ESBL-PE remain asymptomatic, a recent study has shown that 50% will carry the bacteria for 1 month but 10% for up to a year. The additional bad news in this scenario is the fact that bacterial co-resistance was transferred to other antibiotics such a tobramycin, a non-beta lactam antibiotic, that shares genetic resistance genes with ciprofloxacin. References 1 J. Josseaume, L. Verner, W.J. Brady, F.X. Duchateau, Multidrug-resistant bacteria among patients treated in foreign hospitals: management considerations during medical repatriation, J Travel Med,... |
| doi_str_mv | 10.1016/j.tmaid.2017.04.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1888677668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1477893917300480</els_id><sourcerecordid>1888677668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-8c30e9629361bf9409470d1eb44457b7f085637088a5fbfd7cce0ae13da1ab1e3</originalsourceid><addsrcrecordid>eNqFkUtLxDAQx4Movj-BIAUPemmdNNkmFRQW3yB4UM8hTaeatQ9Nssp-e7OuD_DiKYH8_pOZ3xCyQyGjQIvDSRY6bessByoy4BkAWyLrVAqWAuf5crxzIVJZsnKNbHg_icBIcrZK1nLJQbIc1snZuA-2skOwJvHYNmlwqEOHfUiGJglOv2GLzu8ntdXOPaE-Sq7jU9_OkkcMPnkfnMctstLo1uP217lJHi7O70-v0pvby-vT8U1qYj8hlYYBlkVesoJWTcmh5AJqihXnfCQq0YAcFUyAlHrUVE0tjEHQSFmtqa4osk1ysKj74obXKfqgOusNtq3ucZh6RaWUhRBFISO69wedDFPXx-4iVeYiWmFlpNiCMm7w3mGjXpzttJspCmouWU3Up2Q1l6yAq-gwpna_ak-rDuufzLfVCBwvAIwy3iw65Y3F3mBtHZqg6sH-88HJn7xpbW-Nbp9xhv53EuVzBepuvuf5mqlgAFwC-wCH9aHH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1892789339</pqid></control><display><type>article</type><title>Antibiotic self-treatment of travelers' diarrhea: It only gets worse</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Keystone, J.S., MD FRCPC ; Connor, Bradley A., MD</creator><creatorcontrib>Keystone, J.S., MD FRCPC ; Connor, Bradley A., MD</creatorcontrib><description>Even the use of loperamide has been shown to increase the risk of drug resistant gut enteric bacteria when added to antibiotic treatment of TD whereas loperamide use alone did not increase this risk [4] In fact, loperamide appears to be no less effective than an antibiotic in the management of mild to moderate travelers' diarrhea [5] Although the vast majority of those returning from international travel with ESBL-PE remain asymptomatic, a recent study has shown that 50% will carry the bacteria for 1 month but 10% for up to a year. The additional bad news in this scenario is the fact that bacterial co-resistance was transferred to other antibiotics such a tobramycin, a non-beta lactam antibiotic, that shares genetic resistance genes with ciprofloxacin. References 1 J. Josseaume, L. Verner, W.J. Brady, F.X. Duchateau, Multidrug-resistant bacteria among patients treated in foreign hospitals: management considerations during medical repatriation, J Travel Med,...</description><identifier>ISSN: 1477-8939</identifier><identifier>EISSN: 1873-0442</identifier><identifier>DOI: 10.1016/j.tmaid.2017.04.003</identifier><identifier>PMID: 28408320</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acquisitions & mergers ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacteria ; Conflicts of interest ; Diarrhea ; Diarrhea - drug therapy ; Drug dosages ; Drug Resistance, Bacterial ; Enterobacteriaceae - drug effects ; Enterobacteriaceae Infections - drug therapy ; Enterobacteriaceae Infections - microbiology ; Genes ; Health ; Humans ; Infectious Disease ; Infectious diseases ; Prescription Drug Overuse ; Public Health ; Self Care ; Travel ; Travel medicine</subject><ispartof>Travel medicine and infectious disease, 2017-03, Vol.16, p.1-2</ispartof><rights>2017</rights><rights>Copyright Elsevier Limited Mar 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-8c30e9629361bf9409470d1eb44457b7f085637088a5fbfd7cce0ae13da1ab1e3</citedby><cites>FETCH-LOGICAL-c442t-8c30e9629361bf9409470d1eb44457b7f085637088a5fbfd7cce0ae13da1ab1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1477893917300480$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28408320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keystone, J.S., MD FRCPC</creatorcontrib><creatorcontrib>Connor, Bradley A., MD</creatorcontrib><title>Antibiotic self-treatment of travelers' diarrhea: It only gets worse</title><title>Travel medicine and infectious disease</title><addtitle>Travel Med Infect Dis</addtitle><description>Even the use of loperamide has been shown to increase the risk of drug resistant gut enteric bacteria when added to antibiotic treatment of TD whereas loperamide use alone did not increase this risk [4] In fact, loperamide appears to be no less effective than an antibiotic in the management of mild to moderate travelers' diarrhea [5] Although the vast majority of those returning from international travel with ESBL-PE remain asymptomatic, a recent study has shown that 50% will carry the bacteria for 1 month but 10% for up to a year. The additional bad news in this scenario is the fact that bacterial co-resistance was transferred to other antibiotics such a tobramycin, a non-beta lactam antibiotic, that shares genetic resistance genes with ciprofloxacin. References 1 J. Josseaume, L. Verner, W.J. Brady, F.X. Duchateau, Multidrug-resistant bacteria among patients treated in foreign hospitals: management considerations during medical repatriation, J Travel Med,...</description><subject>Acquisitions & mergers</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Conflicts of interest</subject><subject>Diarrhea</subject><subject>Diarrhea - drug therapy</subject><subject>Drug dosages</subject><subject>Drug Resistance, Bacterial</subject><subject>Enterobacteriaceae - drug effects</subject><subject>Enterobacteriaceae Infections - drug therapy</subject><subject>Enterobacteriaceae Infections - microbiology</subject><subject>Genes</subject><subject>Health</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Prescription Drug Overuse</subject><subject>Public Health</subject><subject>Self Care</subject><subject>Travel</subject><subject>Travel medicine</subject><issn>1477-8939</issn><issn>1873-0442</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUtLxDAQx4Movj-BIAUPemmdNNkmFRQW3yB4UM8hTaeatQ9Nssp-e7OuD_DiKYH8_pOZ3xCyQyGjQIvDSRY6bessByoy4BkAWyLrVAqWAuf5crxzIVJZsnKNbHg_icBIcrZK1nLJQbIc1snZuA-2skOwJvHYNmlwqEOHfUiGJglOv2GLzu8ntdXOPaE-Sq7jU9_OkkcMPnkfnMctstLo1uP217lJHi7O70-v0pvby-vT8U1qYj8hlYYBlkVesoJWTcmh5AJqihXnfCQq0YAcFUyAlHrUVE0tjEHQSFmtqa4osk1ysKj74obXKfqgOusNtq3ucZh6RaWUhRBFISO69wedDFPXx-4iVeYiWmFlpNiCMm7w3mGjXpzttJspCmouWU3Up2Q1l6yAq-gwpna_ak-rDuufzLfVCBwvAIwy3iw65Y3F3mBtHZqg6sH-88HJn7xpbW-Nbp9xhv53EuVzBepuvuf5mqlgAFwC-wCH9aHH</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Keystone, J.S., MD FRCPC</creator><creator>Connor, Bradley A., MD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>KB0</scope><scope>L.G</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20170301</creationdate><title>Antibiotic self-treatment of travelers' diarrhea: It only gets worse</title><author>Keystone, J.S., MD FRCPC ; Connor, Bradley A., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-8c30e9629361bf9409470d1eb44457b7f085637088a5fbfd7cce0ae13da1ab1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acquisitions & mergers</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Conflicts of interest</topic><topic>Diarrhea</topic><topic>Diarrhea - drug therapy</topic><topic>Drug dosages</topic><topic>Drug Resistance, Bacterial</topic><topic>Enterobacteriaceae - drug effects</topic><topic>Enterobacteriaceae Infections - drug therapy</topic><topic>Enterobacteriaceae Infections - microbiology</topic><topic>Genes</topic><topic>Health</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Prescription Drug Overuse</topic><topic>Public Health</topic><topic>Self Care</topic><topic>Travel</topic><topic>Travel medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keystone, J.S., MD FRCPC</creatorcontrib><creatorcontrib>Connor, Bradley A., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Travel medicine and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keystone, J.S., MD FRCPC</au><au>Connor, Bradley A., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic self-treatment of travelers' diarrhea: It only gets worse</atitle><jtitle>Travel medicine and infectious disease</jtitle><addtitle>Travel Med Infect Dis</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>16</volume><spage>1</spage><epage>2</epage><pages>1-2</pages><issn>1477-8939</issn><eissn>1873-0442</eissn><abstract>Even the use of loperamide has been shown to increase the risk of drug resistant gut enteric bacteria when added to antibiotic treatment of TD whereas loperamide use alone did not increase this risk [4] In fact, loperamide appears to be no less effective than an antibiotic in the management of mild to moderate travelers' diarrhea [5] Although the vast majority of those returning from international travel with ESBL-PE remain asymptomatic, a recent study has shown that 50% will carry the bacteria for 1 month but 10% for up to a year. The additional bad news in this scenario is the fact that bacterial co-resistance was transferred to other antibiotics such a tobramycin, a non-beta lactam antibiotic, that shares genetic resistance genes with ciprofloxacin. References 1 J. Josseaume, L. Verner, W.J. Brady, F.X. Duchateau, Multidrug-resistant bacteria among patients treated in foreign hospitals: management considerations during medical repatriation, J Travel Med,...</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28408320</pmid><doi>10.1016/j.tmaid.2017.04.003</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-8939 |
| ispartof | Travel medicine and infectious disease, 2017-03, Vol.16, p.1-2 |
| issn | 1477-8939 1873-0442 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1888677668 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acquisitions & mergers Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Bacteria Conflicts of interest Diarrhea Diarrhea - drug therapy Drug dosages Drug Resistance, Bacterial Enterobacteriaceae - drug effects Enterobacteriaceae Infections - drug therapy Enterobacteriaceae Infections - microbiology Genes Health Humans Infectious Disease Infectious diseases Prescription Drug Overuse Public Health Self Care Travel Travel medicine |
| title | Antibiotic self-treatment of travelers' diarrhea: It only gets worse |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A12%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20self-treatment%20of%20travelers'%20diarrhea:%20It%20only%20gets%20worse&rft.jtitle=Travel%20medicine%20and%20infectious%20disease&rft.au=Keystone,%20J.S.,%20MD%20FRCPC&rft.date=2017-03-01&rft.volume=16&rft.spage=1&rft.epage=2&rft.pages=1-2&rft.issn=1477-8939&rft.eissn=1873-0442&rft_id=info:doi/10.1016/j.tmaid.2017.04.003&rft_dat=%3Cproquest_cross%3E1888677668%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1892789339&rft_id=info:pmid/28408320&rft_els_id=1_s2_0_S1477893917300480&rfr_iscdi=true |